PROKIDNEY CORP. (PROK) Executive Compensation
PROKIDNEY CORP. (PROK) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PROK
CIK: 1850270
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerDanica Dilligard
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359349 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001628280-26-057713 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001628280-26-057710 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000895421-26-000226 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342397 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342373 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 | 0001193125-26-336856 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296160 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001193125-26-271337 | View SEC Doc Filr Page |
| 3 | 2026-06-10 | 2026-06-01 | 3 | 0001193125-26-265815 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248262 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248259 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248256 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248249 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248226 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248221 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-248215 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-28 | 8-K | 0001193125-26-248210 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001193125-26-225848 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-225841 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-30 | — | SCHEDULE 13D/A Filing | 0001140361-26-018258 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001140361-26-018234 | View SEC Doc Filr Page |
| ARS | 2026-04-17 | 2025-12-31 | ARS | 0001140361-26-015371 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-17 | — | DEFA14A | 0001140361-26-015369 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-17 | 2026-05-28 | DEF 14A | 0001140361-26-015362 | View SEC Doc Filr Page |